Hongming Miao

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Topics

Top Venues

Signal transduction and targeted therapy

Science advances

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Yuan Gao, Kun Zhao, Yulan Huang, Dapeng Zhang, Na Luo, Xiaoqing Peng, Feng Yang, Weidong Xiao, Meng Wang, Rongchen Shi, Hongming Miao
Lanosterol synthase deficiency promotes tumor progression by orchestrating PDL1-dependent tumor immunosuppressive microenvironment. MedComm 5 (4) (2024)
Yuan Gao, Kun Zhao, Yulan Huang, Dapeng Zhang, Na Luo, Xiaoqing Peng, Feng Yang, Weidong Xiao, Meng Wang, Rongchen Shi, Hongming Miao
Lanosterol synthase deficiency promotes tumor progression by orchestrating PDL1-dependent tumor immunosuppressive microenvironment. MedComm 5 (4) (2024)
Yuan Gao, Kun Zhao, Yulan Huang, Dapeng Zhang, Na Luo, Xiaoqing Peng, Feng Yang, Weidong Xiao, Meng Wang, Rongchen Shi, Hongming Miao
Lanosterol synthase deficiency promotes tumor progression by orchestrating PDL1-dependent tumor immunosuppressive microenvironment. MedComm 5 (4) (2024)
Yuan Gao, Liqing Yu, Hongming Miao
Bispecific immune molecule PD1-IL2v: a new therapeutic strategy for pancreatic ductal adenocarcinoma. Signal transduction and targeted therapy 8 (1) (2023)
Xia Kang, Yuqi Gao, So-Ichiro Fukada, Hongming Miao
FAP senescence: a critical event in muscle regeneration. Signal transduction and targeted therapy 8 (1) (2023)
Xia Kang, Yuqi Gao, So-Ichiro Fukada, Hongming Miao
FAP senescence: a critical event in muscle regeneration. Signal transduction and targeted therapy 8 (1) (2023)
Xia Kang, Yuqi Gao, So-Ichiro Fukada, Hongming Miao
FAP senescence: a critical event in muscle regeneration. Signal transduction and targeted therapy 8 (1) (2023)
Yuancai Xiang, Irfan Ullah, Hongming Miao
Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti-programmed death 1/programmed death ligand 1. MedComm 4 (5) (2023)
Yuancai Xiang, Meng Wang, Hongming Miao
Ketogenic diet: new avenues to overcome colorectal cancer. Signal transduction and targeted therapy 7 (1) (2022)
Yawei Wang, Binlin Tang, Lei Long, Peng Luo, Wei Xiang, Xueru Li, Huilan Wang, Qingzhi Jiang, Xu Tan, Shenglin Luo, Huijuan Li, Ziwen Wang, Zelin Chen, Yu Leng, Zhongyong Jiang, Yang Wang, Le Ma, Rui Wang, Chunyu Zeng, Zujuan Liu, Yu Wang, Hongming Miao, Chunmeng Shi
Improvement of obesity-associated disorders by a small-molecule drug targeting mitochondria of adipose tissue macrophages. Nature communications 12 (1) (2021)
Wei Xiang, Rongchen Shi, Dapeng Zhang, Xia Kang, Lili Zhang, Jing Yuan, Xuan Zhang, Hongming Miao
Dietary fats suppress the peritoneal seeding of colorectal cancer cells through the TLR4/Cxcl10 axis in adipose tissue macrophages. Signal transduction and targeted therapy 5 (1) (2020)
Yuancai Xiang, Kun Zhao, Yi-Quan Tang, Rongyang Dai, Hongming Miao
Modulating serine palmitoyltransferase-deoxysphingolipid axis in cancer therapy. MedComm 2 (1) (2020)
Rongchen Shi, Hongming Miao
Dietary intervention, a promising adjunct for cancer therapy. Signal transduction and targeted therapy 5 (1) (2020)
Li Tan, Xia Kang, Bo Zhang, Shangen Zheng, Bo Liu, Tiantian Yu, Fan Yang, Qiongshu Wang, Hongming Miao
Plasma therapy cured a COVID-19 patient with long duration of viral shedding for 49 days: The clinical features, laboratory tests, plasma therapy, and implications for public health management. MedComm (2020)
Kun Zhao, Hongming Miao
Targeting metabolic/epigenetic pathways: a potential strategy for cancer therapy in diffuse intrinsic pontine gliomas. Signal transduction and targeted therapy 5 (1) (2020)
Rongchen Shi, Yi-Quan Tang, Hongming Miao
Metabolism in tumor microenvironment: Implications for cancer immunotherapy. MedComm 1 (1) (2020)
Yu Zhou, Juan Lei, Qichao Xie, Lei Wu, Shengwei Jin, Bo Guo, Xiang Wang, Guifang Yan, Qi Zhang, Huakan Zhao, Jiangang Zhang, Xiao Zhang, Jingchun Wang, Jiaqi Gu, Xiaoli Liu, Duyun Ye, Hongming Miao, Charles Nicholas Serhan, Yongsheng Li
Fibrinogen-like protein 2 controls sepsis catabasis by interacting with resolvin Dp5. Science advances 5 (11) (2019)
Dongbo Liu, Hongping Miao, Yuanyin Zhao, Xia Kang, Shenglan Shang, Wei Xiang, Rongchen Shi, Along Hou, Rui Wang, Kun Zhao, Yingzhe Liu, Yue Ma, Huan Luo, Hongming Miao, Fengtian He
NF-κB potentiates tumor growth by suppressing a novel target LPTS. Cell communication and signaling : CCS 15 (1) (2017)